Nathalie Ledee/LinkedIn
Sep 29, 2025, 11:50
Nathalie Ledee Highlights Emerging Insights from ESHRE 2025
Nathalie Ledee, Obstetrician Gynecologist and PhD, CEO at MatriceLab, shared a post on LinkedIn:
“It was a great pleasure to spend a whole day immersed in the exciting world of reproductive immunology at this wonderful, huge ESHRE2025 congress. It became clear that immunosuppressive therapies cannot be prescribed indiscriminately. Precision care requires a diagnosis. Another good news is that the concept that endometrial immune equilibrium may help weak embryos (while not being necessary for top-quality ones) is now emerging. Further studies will reveal more about this crucial issue.”
-
May 7, 2026, 16:23Amelia Degenkolb: ACOG 2026 Brings Innovation, Partnership and Patient Access Into Focus
-
May 7, 2026, 16:15New FIGO-IPPS Classification for Female Chronic Pelvic Pain – IJGO
-
May 7, 2026, 16:05Marco Zaccaria: How Uterine Fibroids Affect Latina Women
-
May 7, 2026, 12:36Adela Serban: Advanced Imaging Technique Enhances Uterine Imaging with 3D Ultrasound and Uterine Tracing
-
May 7, 2026, 12:26David Sable Highlights The Quest for Fertility as a Deep and Valuable Read
-
May 7, 2026, 12:20May Is Preeclampsia Awareness Month – The Society for Maternal-Fetal Medicine
-
May 7, 2026, 12:15PCOS Symptoms Should Not Be Dismissed – PCOS Awareness Association
-
May 7, 2026, 12:08Marco Zaccaria: The Role of the Junctional Zone in the Management of Adenomyosis With Infertility
-
May 7, 2026, 12:04Emad Sedeek: Understanding the Differences in PGT-A, PGT-M and PGT-P Embryogenetic Testing